Blog |

February 7, 2020
By cppiadmin
No Comments

Op-ed: Let’s open door to Canada for lower medicine prices

Today, New Mexico Senator Mary Kay Papen, President Pro Tempore Las Cruces and Kathy Kunkel, New Mexico Department of Health, published an op-ed highlighting the potential benefits of drug importation from Canada. As they write:…

January 9, 2020
By cppiadmin
No Comments

3rd Annual Shkreli Awards

in Big Pharma, Consumer Impact

Earlier this week, the Lown Institute released finalists in its annual Shkreli Awards recognizing the 'worst examples of profiteering and dysfunction in health care.' The awards are named after Martin Shkreli, who dramatically and overwhelmingly…

January 9, 2020
By cppiadmin
No Comments

Palm Beach Post: Importing drugs from Canada unproven, but may be only ready Rx for what ails US

in Big Pharma, Consumer Impact, Drug prices

This Palm Beach Post op-ed captures the high stakes high drug cost debate and potential promise of importation from Canada. In fact, it is a matter of life-and-death for millions of Floridians, as the article…

January 3, 2020
By cppiadmin
No Comments

New Year, New Rx Price Hikes

in Big Pharma, Consumer Impact, Drug prices

Unfortunately, 2020 has not brought the long awaited fresh beginning to the tired refrain of outrageous price hikes. Big Pharma raised U.S. list prices on more than 250 drugs this week, according to analysts. Most…

December 18, 2019
By cppiadmin
No Comments

HHS Releases Draft Plan to Allow Rx Importation

in Consumer Impact, Drug prices, Safety

Today, Health and Human Services (HHS) released draft plans for prescription drug importation into the U.S., recognizing that it is safe and affordable. While finalizing and implementing the plan could take many years, personal prescription…

December 5, 2019
By cppiadmin
No Comments

FDA Nominee Shares Thoughts on Rx Importation

in Consumer Impact, Drug prices, Safety

This week, a Senate committee moved to advance the nomination of Dr. Stephen Hahn to lead the Food and Drug Administration (FDA). Dr. Hahn is a radiation oncologist and cancer researcher with specializations in treating…

December 4, 2019
By cppiadmin
No Comments

CPPI: Showing Americans a Safe, Affordable Alternative to Rising Rx Prices

in Big Pharma, Consumer Impact, CPPI News, Drug prices, Safety

Recently, our Executive Director was interviewed for the Canada Online Health website regarding what we have learned through our community of supporters who import safe and affordable medications from Canada. Cooley focused on what people…

November 15, 2019
By cppiadmin
No Comments

AARP Releases Report on Rx Prices

in Consumer Impact, Drug prices

This week, AARP released a report showing that drug prices for more than 260 brand name drugs increased more than twice as fast as inflation in 2018. While the rate of inflation was 2.4 percent,…

November 12, 2019
By cppiadmin
No Comments

Study: Millions of People have Lost Someone Because of Inability to Pay for Care

in Consumer Impact, Drug prices, Safety

This headline is a wake-up call! More than 13% of American adults - or about 34 million people - report that they know at least one family member of friend who has died in the…

November 7, 2019
By cppiadmin
No Comments

Shining a Light Into the Shadows

in Big Pharma, Consumer Impact, CPPI News, Drug prices, Safety

This week, CPPI's Executive Director attended the ICANN Meeting in Montreal, Canada. ICANN stands for the International Corporation for Assigned Names and Numbers and they are the governing body for the Internet. This meeting was…